Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Clo… (NCT01325792) | Clinical Trial Compass
CompletedNot Applicable
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
United States104 participantsStarted 2011-02
Plain-language summary
Prospective, multicenter, observational study to evaluate performance of GORE® BIO-A® Tissue Reinforcement when used to reinforce midline fascial closure in single-staged open complex ventral incisional hernia repair.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects will be informed about the study, and will have read; understood and signed the informed consent and authorization to use their PHI, as applicable
* Subjects willing and able to submit to postoperative follow-up evaluations including quality of life assessments up to 24 months after surgery
* Subjects of either gender that are at least the age of 18 years
* Subjects will have a Body-Mass Index (BMI) of \< 40
* Subjects will be undergoing single-staged open complex ventral incisional hernia repair with the retrorectus or intraperitoneal placement technique of the GORE® BIO-A® Tissue Reinforcement
* Subjects in which intraoperatively their surgical field/wound is characterized either a Type 2 or Type 3 in Table 1 in Section 12.0
* Subjects with a hernia defect \> 9 cm2 large when measured intraoperatively
* Subjects in which the required mobility for midline fascial closure without excessive tension to reapproximate the rectus abdominis muscle intraoperatively can be achieved
* Subjects in which one unit of GORE® BIO-A® Tissue Reinforcement will adequately reinforce the midline fascial closure with at least 4 cm of overlap laterally
Exclusion Criteria:
* Subjects who, in the surgeon's opinion, would have a difficult time comprehending or complying with the requirements of the study
* Subjects with a BMI \> 40
* Subjects with evidence of pre-existing systemic infections
* Subjects with cirrhosis or are currently being treated with dialysis
* Sub…